ヨーロッパ泌尿器科学会でベストポスター賞受賞(2演題3年連続)

当教室の研究は独創性、革新性に優れ、ハイレベルな国際学会であるヨーロッパ泌尿器科学会(EAU)および米国泌尿器科学会(AUA)の年次総会に多数の演題が採択されています。

最近3年間のEAUとAUAの採択数は2014年=7、2015年=9、2016年=10で、このうち6演題がベストポスター賞(毎年2演題、3年連続)、1演題が最優秀賞を獲得しました。

ベストポスター賞と最優秀賞の演題は以下の通りです。

2016年
■31th EAU Annual Congress (Munich), The EAU acknowledges the selection of the Best Poster in Poster Session 73 entitled: Scientific basis of experimental therapy in bladder cancer.
STAT1 inhibition restored chemotherapy sensitivity in cisplatin/gemcitabine resistant bladder cancer
林 哲太郎

■31th EAU Annual Congress (Munich), The EAU acknowledges the selection of the Best Poster in Poster Session 10 entitled: Basic research in renal tumours: Looking for the right treatment for the right patient.
TSPAN8 expression in renal cell carcinoma is a poor prognostic factor and a novel therapeutic target
林 哲太郎

2015年
■30th Anniversary Congress of the European Association of Urology (Madrid), Best Poster Award
Impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in metastatic renal cell carcinoma patients.
亭島 淳

■30th Anniversary Congress of the European Association of Urology (Madrid), Best Poster Award
Comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients.
正路 晃一

2014年
★最優秀賞 29th Annual Congress of the European Association of Urology, Stockholm, 10-15 March 2014 First Prize for the Best Abstract by a resident with a presentation in Poster Session 4 entitled: Molecular diagnostic and biomarkers of bladder cancer.
Notch2 promotes bladder cancer progression: Pre-clinical rationale for a novel targeted therapy.
林 哲太郎

■29th Annual Congress of the European Association of Urology, Stockholm, 10-15 March 2014 The European Association of Urology acknowledges the selection of the Best Poster in Poster Session 42 entitled: Novel experimental therapies and resistance in urothelial cancer.
Targeting HER2 with trastuzumab-DM1 (T-DM1) is highly effective in preclinical models of HER2-overexpressing bladder cancer.
林 哲太郎

robot


ヨーロッパ泌尿器科学会2016(ミュンヘン)会場前にて